Primary hypothyroidism
ICD-10 E03.9 · ICD-11 5A00

Treatment of Primary Hypothyroidism with Elevated TSH and Normal Free Thyroxine

Subclinical hypothyroidism is defined by an elevated thyroid-stimulating hormone (TSH) level alongside a normal free thyroxine (fT4). This biochemical pattern does not automatically warrant treatment — specific criteria determine when intervention is appropriate.

Clinical Scenario

This protocol applies to patients with elevated TSH and a normal fT4 level, where at least one of the following criteria is also present:

TSH level greater than 10 mIU/L  —  or  —  elevated thyroid peroxidase (TPO) antibody

Most patients with elevated TSH and normal fT4 do not meet criteria for treatment unless one of these thresholds is reached.

Treatment Approach

When the above criteria are met, levothyroxine therapy is considered. The full structured protocol details how this therapy is evaluated, initiated, and monitored — the complete regimen is available below.

Instant Access to Structured Evidence-Based Regimens

References

  1. Subclinical hypothyroidism is a biochemical finding of an elevated TSH level with a normal FT4 level.
  2. In nonpregnant patients with subclinical hypothyroidism, levothyroxine therapy should be considered when the TSH level is greater than 10 mIU per L or the TPO antibody level is elevated.
  3. Most patients with subclinical hypothyroidism do not benefit from treatment unless the thyroid-stimulating hormone level is greater than 10 mIU per L or the thyroid peroxidase antibody is elevated.
View source ↗